Friday, 28 August 2026European Markets

Monetary Policy

2 articles

ECB Keeps Dovish Stance as Fed Holds Restrictive Rates, EUR/USD Pressure Mounts

ECB Keeps Dovish Stance as Fed Holds Restrictive Rates, EUR/USD Pressure Mounts

The European Central Bank maintains its gradual rate-cutting path while the Federal Reserve signals prolonged restrictive policy, driving currency divergence. Fed's Jeff Schmid warns further rate cuts risk persistent inflation, contrasting sharply with ECB Vice President Luis de Guindos citing positive inflation news. The policy split widens the 2-year US-German yield spread, threatening capital outflows from European markets.

ViaNews Editorial Team (Europe)
Federal Reserve signals slower rate cuts in 2026 as labor market stays resilient

Federal Reserve signals slower rate cuts in 2026 as labor market stays resilient

Fed governors Philip Jefferson and Chris Waller indicated the central bank will slow its pace of rate cuts in 2026, citing strong employment data and rates still restricting economic activity. The shift creates diverging prospects for European financial markets tied to dollar movements and transatlantic capital flows.

ViaNews Editorial Team (Europe)
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Turnover Meets Maturing Enterprise ROI, Under Rising Transparency Pressure
The AI industry is showing signs of transition from hype to accountability: leadership instability at frontier labs (OpenAI's Brad Lightcap departing, Alphabet shares dropping on a researcher exit) coincides with hard enterprise ROI data emerging from AI vendors (Arkestro's procurement savings, Multiverse Computing's compression throughput gains, CloneOps.ai's labor-displacement modeling). Simultaneously, platforms and regulators are moving toward content transparency and abuse controls (Anthropic and Google watermarking, Spotify AI-artist labeling), signaling that AI's economic footprint is now large enough to draw both investor and policy scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com